DESIGN THERAPEUTICS INC shareholders Q4 2022

DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 86 filers reported holding DESIGN THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.4%.

DESIGN THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 6,526,476$66,961,64424.44%
Cormorant Asset Management, LP 5,150,000$52,8393.54%
Logos Global Management LP 2,797,501$28,702,3603.36%
RA Capital Management 2,971,231$30,484,8300.62%
Ghost Tree Capital, LLC 82,853$850,0000.36%
Avoro Capital Advisors LLC 2,272,222$23,312,9980.35%
EcoR1 Capital, LLC 884,903$9,079,1050.28%
SILVERARC CAPITAL MANAGEMENT, LLC 57,025$585,0770.17%
Ikarian Capital, LLC 48,500$497,6100.12%
Rock Springs Capital Management LP 460,391$4,723,6120.11%
Virtus Investment Advisers, Inc. 14,400$147,7440.10%
Virtus ETF Advisers LLC 15,774$161,8410.08%
Baker Brothers Advisors 692,131$7,101,2640.04%
Ikarian Capital, LLC 11,568$118,6890.03%
Rafferty Asset Management, LLC 243,585$2,499,1820.02%
GSA CAPITAL PARTNERS LLP 13,619$1400.02%
Jump Financial, LLC 30,400$311,9040.02%
Caption Management, LLC 90,000$923,4000.01%
E Fund Management Co., Ltd. 12,523$1280.01%
ExodusPoint Capital Management, LP 50,731$5210.01%
External links

This page lists DESIGN THERAPEUTICS INC's shareholders in Q4 2022. To view DESIGN THERAPEUTICS INC's shareholder history, click here.